NasdaqGS:RVMDBiotechs
Revolution Medicines (RVMD) Stock Looks Strong On Returns But Expensive On Value
Revolution Medicines has delivered very strong long term shareholder returns over the past five years, yet the broader valuation checks now suggest the stock is priced on the rich side rather than as a clear bargain.
Revolution Medicines has returned about 7x over the past 5 years, which puts extra pressure on today’s buyers to justify the current share price.
Recent interest around its RAS(ON) inhibitor partnerships and demand for daraxonrasib can support high growth expectations, but the...